MicroRNA‑181 serves an oncogenic role in breast cancer via the inhibition of SPRY4

Yifu Tian, Xiaodan Fu, Qingling Li, Ying Wang, Dan Fan, Qin Zhou, Weilu Kuang, Liangfang Shen

Open source

DOI
10.3892/mmr.2018.9572
Published
2018-10-22
Container
Molecular Medicine Reports
Publisher
Spandidos Publications
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3892/mmr.2018.9572,
  title = {MicroRNA‑181 serves an oncogenic role in breast cancer via the inhibition of SPRY4},
  author = {Yifu Tian and Xiaodan Fu and Qingling Li and Ying Wang and Dan Fan and Qin Zhou and Weilu Kuang and Liangfang Shen},
  year = {2018},
  journal = {Molecular Medicine Reports},
  doi = {10.3892/mmr.2018.9572},
  url = {https://doi.org/10.3892/mmr.2018.9572}
}

RIS

TY  - JOUR
TI  - MicroRNA‑181 serves an oncogenic role in breast cancer via the inhibition of SPRY4
AU  - Yifu Tian
AU  - Xiaodan Fu
AU  - Qingling Li
AU  - Ying Wang
AU  - Dan Fan
AU  - Qin Zhou
AU  - Weilu Kuang
AU  - Liangfang Shen
PY  - 2018
JO  - Molecular Medicine Reports
DO  - 10.3892/mmr.2018.9572
UR  - https://doi.org/10.3892/mmr.2018.9572
ER  - 

APA

Tian, Y., Fu, X., Li, Q., Wang, Y., Fan, D., Zhou, Q., Kuang, W., & Shen, L. (2018). MicroRNA‑181 serves an oncogenic role in breast cancer via the inhibition of SPRY4. Molecular Medicine Reports. https://doi.org/10.3892/mmr.2018.9572

Source records